Looking for volunteers
Effectiveness of a Powered Exoskeleton Combined With FES for Patients With Chronic SCI: a RCT
NCT05187650 · Mario Widmer · Updated 18 Dec 2025
- What is being tested
- Ekso (EksoNR, Ekso Bionics); FES (RehaMove2, Hasomed)
- For
- Spinal Cord Injuries; Gait Disorders, Neurologic
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 34 people. The full rules are on the registry page.
- Where
- Switzerland
- When
- Starts or started 18 March 2022, ends 31 Dec 2027. Registered 12 Jan 2022.
- Results
- None posted yet.
In the researchers' words
While there are a number of prospective studies evaluating powered exoskeletons in SCI patients, to date, not a single well-designed, randomized clinical trial has been published. However, there is evidence for beneficial effects of over-ground exoskeleton therapy on walking function post-intervention from a meta-analysis on non-randomized, uncontrolled studies. Functional electrical stimulation (FES), on the other hand, is a common and established method for the rehabilitation of persons with SCI and has been demonstrated to be beneficial in, e.g., improving muscle force, power output and endurance. Combining FES and overground robotic therapy within the same therapy session could potentially merge and potentiate the effects of each separate treatment, making it a very powerful and efficient therapy method. Up to date, however, comparative studies evaluating benefits of this combined approach (i.e., powered exoskeleton and FES) to robotic therapy without FES are missing.
Sites
- Swiss Paraplegic CentreNottwil, Canton of Lucerne, Switzerland
